Clinical Trials

Showing trials with last updates posted in 2024.

NCT06735391 | RECRUITING | PHASE3
516 participants

A Clinical Study of JMT101 in Combination With Osimertinib Versus Osimertinib Alone as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Sensitive Mutations

Study Type:
INTERVENTIONAL
Last Updated:
2024-12-16
Start Date:
2024-10-23
Completion:
2026-09-30
Conditions
  • Locally Advanced or Metastatic Non-squamous NSCLC
  • Harboring EGFR Sensitive Mutations NSCLC
  • Previously Untreated Systematically NSCLC
Interventions
  • DRUG
No Results Yet
NCT06735235 | COMPLETED | PHASE1
27 participants

Salivary Fluoride Clearance

Study Type:
INTERVENTIONAL
Last Updated:
2024-12-16
Start Date:
2021-07-14
Completion:
2021-07-29
Conditions
  • Caries
Interventions
  • DRUG
No Results Yet
NCT06734624 | NOT_YET_RECRUITING
750 participants

The Microbiome in Blood Cancer and HLH

Study Type:
OBSERVATIONAL
Last Updated:
2024-12-16
Start Date:
2025-01-01
Completion:
2039-12-31
Conditions
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • Follicular Lymphoma (FL)
  • Haemophagocytic Lymphohistiocytosis
No Results Yet
NCT06734429 | COMPLETED
15 participants

Urinary Artificial Sphincter in Children

Study Type:
OBSERVATIONAL
Last Updated:
2024-12-16
Start Date:
2022-11-20
Completion:
2023-01-31
Conditions
  • Neurogenic Bladder Disorder
  • Bladder Dysfunction
  • Spina Bifida
  • Urinary Incontinence Due to Urethral Sphincter Incompetence
  • Child, Only
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page